Dr. Dayan Goodenowe joins Julie Gregory to discuss his new book, “Breaking Alzheimer’s: A 15 Year Crusade to Expose the Cause and Deliver the Cure.” He talks about how his research lead him to plasmalogens and how they relate to neurological health. He explains what goes wrong biochemically as dementia develops and highlights age-related diminishing plasmalogen levels as a major driver of disease. He outlines his research showing that ApoE4 carriers may require more plasmalogens to maintain cognition, and he identifies tests and supplements to support plasmalogen levels. Finally, they discuss the unprecedented results of Dr. Goodenowe’s newly completed clinical trial that he just reported on at the Alzheimer’s Association International Conference.